Publications by authors named "Craig Sprenger"

5Publications

A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.

Clin Pharmacol Drug Dev 2019 01 22;8(1):49-59. Epub 2018 May 22.

eResearch Technology, Inc, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.442DOI Listing
January 2019

Extended-duration dosing and distribution of dalbavancin into bone and articular tissue.

Antimicrob Agents Chemother 2015 Apr 5;59(4):1849-55. Epub 2015 Jan 5.

Durata Therapeutics, Inc., Branford, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.04550-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356775PMC
April 2015

Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.

J Clin Pharmacol 2009 Nov 8;49(11):1353-62. Epub 2009 Sep 8.

Clinical Research, Novo Nordisk, Inc, Princeton, NJ 08540, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270009339189DOI Listing
November 2009